Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Fumagalli and Roberto Rossotti.
Connection Strength
0.394
-
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. J Infect. 2020 10; 81(4):e11-e17.
Score: 0.223
-
Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021 04; 53(8):2912-2922.
Score: 0.059
-
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy. PLoS One. 2020; 15(11):e0242765.
Score: 0.057
-
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J Infect. 2020 Sep; 81(3):e90-e92.
Score: 0.056